These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3104340)

  • 21. Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein.
    Yuan R; Chen X; Chen Y; Gu T; Xi H; Duan Y; Sun B; Yu X; Jiang C; Liu X; Wu C; Kong W; Wu Y
    Appl Microbiol Biotechnol; 2014 Feb; 98(4):1547-55. PubMed ID: 24241896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus.
    Perrin P; Versmisse P; Delagneau JF; Lucas G; Rollin PE; Sureau P
    J Biol Stand; 1986 Apr; 14(2):95-102. PubMed ID: 3531213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
    Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
    J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
    Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
    Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.
    Wiktor TJ; Macfarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7194-8. PubMed ID: 6095272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro ELISA Test to Evaluate Rabies Vaccine Potency.
    Jallet C; Tordo N
    J Vis Exp; 2020 May; (159):. PubMed ID: 32449742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
    Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-protein based ELISA as a potency test for rabies vaccines.
    Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
    Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modification of the single radial immunodiffusion potency test (SRD) for rabies vaccines.
    Vogel I; Kundi M; Gerstl F
    J Biol Stand; 1989 Jan; 17(1):75-83. PubMed ID: 2493456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
    Morgeaux S; Poirier B; Ragan CI; Wilkinson D; Arabin U; Guinet-Morlot F; Levis R; Meyer H; Riou P; Shaid S; Volokhov D; Tordo N; Chapsal JM
    Vaccine; 2017 Feb; 35(6):966-971. PubMed ID: 28081969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic variants of rabies virus.
    Wiktor TJ; Koprowski H
    J Exp Med; 1980 Jul; 152(1):99-112. PubMed ID: 6156982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune efficacy of rabies virus glycoprotein expressed by baculovirus vector].
    Chen Q; Zhang SF; Liu Y; Fu YH; Sun CL; Yang Y; Gong T; Song FF; Hu RL
    Bing Du Xue Bao; 2012 Sep; 28(5):501-5. PubMed ID: 23233923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of the single radial immunodiffusion method for controlling the activity of cultured rabies vaccines].
    Poliushkina GS; Dzagurov SG; Romanova LN; Ferguson M
    Vopr Virusol; 1985; 30(1):107-10. PubMed ID: 3922119
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination.
    Atanasiu P; Perrin P; Delagneau JF
    Dev Biol Stand; 1980; 46():207-15. PubMed ID: 6988255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro potency tests: challenges encountered during method development.
    Yomayuza CL; Thiel HJ; König M
    Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency of veterinary rabies vaccines in The Netherlands: a case for continued vigilance.
    Rooijakkers EJ; Nieuwenhuijs JH; Vermeulen AA; van Steenis G; Osterhaus AD
    Vet Q; 1996 Dec; 18(4):146-50. PubMed ID: 8972063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations.
    Perrin P; Joffret ML; Oth D; Leclerc C; Sureau P; Thibodeau L
    Vaccine; 1988 Aug; 6(4):331-8. PubMed ID: 2461004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.